Anuh Pharma Limited is engaged in the business of manufacturing and selling bulk drugs and chemicals. The Company's products include active pharmaceutical ingredients and corticosteroids. Its active pharmaceutical ingredients include macrolides, anti-TB, anti-malarial, antibacterial, anti-hypertension, expectorant, quinolones, intermediates and under development. Its macrolides products include erythromycin, erythromycin ethyl succinate, erythromycin stearate, erythromycin estolate, erythromycin propionate, erythromycin phosphate, and others. Its anti-malarial products include sulfadoxine, pyrimethamine, and others. The Company's anti-hypertension products include losartan potassium, telmisartan and atorvastatin calcium. The Company's corticosteroids include anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, antihistamines and under development. Its anti-inflammatory products include dexamethasone Na phosphate, mometasone furoate and clobetasol butyrate.As of 26 May 2026, ANUH PHARMA LIMITED share price is ₹76.39. The stock opened at ₹75.58, compared to its previous close of ₹75.58. During today's trading session, ANUH PHARMA LIMITED share price moved in the range of ₹75.58 to ₹76.90, with an average price of ₹76.24 for the day. Looking at its last 52-week, the stock has touched a low of ₹75.58 and a high of ₹76.90. On the performance front, ANUH PHARMA LIMITED share price has declined by 1.22% over the last six months and is down 26.42% on a year-on-year basis.
The market capitalization of ANUH PHARMA LIMITED is ₹765 Crs, with a P/E ratio of 18.6 and a dividend yield of 1.97%.